S&P 500 Futures
(0.09%) 5 332.25 points

Dow Jones Futures
(0.03%) 40 148 points

Nasdaq Futures
(0.14%) 18 662 points

Oil
(-0.09%) $79.99

Gas
(0.57%) $2.64

Gold
(1.10%) $2 443.90

Silver
(2.82%) $32.14

Platinum
(0.40%) $1 094.40

USD/EUR
(-0.03%) $0.920

USD/NOK
(-0.07%) $10.67

USD/GBP
(0.02%) $0.787

USD/RUB
(-0.27%) $90.72

Realtime updates for Toleranzia AB [TOL.ST]

Exchange: STO Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Last Updated20 May 2024 @ 04:33

25% discount on Stockinvest.us - Use code: Podcast

-16.40% SEK 0.530

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 04:33):

Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease...

Stats
Today's Volume	97 458.00
Average Volume	169 623
Market Cap	116.93M
EPS	SEK-0.00963 ( 2023-09-30 )
Next earnings date	( SEK0 ) 2024-06-06
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-13.25
ATR14	SEK0.0140 (2.64%)

Toleranzia AB Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Toleranzia AB Financials

Annual	2023
Revenue:	SEK51.27M
Gross Profit:	SEK51.24M (99.95 %)
EPS:	SEK-0.0378

FY	2023
Revenue:	SEK51.27M
Gross Profit:	SEK51.24M (99.95 %)
EPS:	SEK-0.0378

FY	2022
Revenue:	SEK35.37M
Gross Profit:	SEK70.62M (199.69 %)
EPS:	SEK-0.0767

FY	2021
Revenue:	SEK0.00
Gross Profit:	SEK27.12M (0.00 %)
EPS:	SEK-0.0596

Financial Reports:

No articles found.

Toleranzia AB Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Toleranzia AB

Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.